{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:49:55Z","timestamp":1762112995975,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Medical University, Lublin, Poland","award":["MNsd560"],"award-info":[{"award-number":["MNsd560"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.cbi.2016.06.031","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T23:52:44Z","timestamp":1467503564000},"page":"407-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PB","title":["Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats"],"prefix":"10.1016","volume":"259","author":[{"given":"Jolanta El\u017cbieta","family":"Pastryk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rusek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Be\u0142towski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2016.06.031_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ije\/dyr164","volume":"41","author":"Lewden","year":"2012","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.cbi.2016.06.031_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1126\/science.271.5250.755","article-title":"Results on news AIDS drugs bring cautious optimism","volume":"271","author":"Cohen","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cbi.2016.06.031_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13181-013-0325-8","article-title":"A\u00a0review of the toxicity of HIV medications","volume":"10","author":"Margolis","year":"2014","journal-title":"J.\u00a0Med. Toxicol."},{"key":"10.1016\/j.cbi.2016.06.031_bib4","series-title":"Internal Diseases, Medycyna Praktyczna","first-page":"2178","author":"Szczeklik","year":"2010"},{"key":"10.1016\/j.cbi.2016.06.031_bib5","first-page":"1332","article-title":"Lipodystrophy and metabolic disorders as a complication of antiretroviral therapy","volume":"67","author":"Boci\u0105ga-Jasik","year":"2010","journal-title":"Przegl. Lek."},{"key":"10.1016\/j.cbi.2016.06.031_bib6","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(05)61703-5","article-title":"FDA warns of potential protease-inhibitor link to hyperglycemia","volume":"349","author":"Ault","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2016.06.031_bib7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cbi.2016.06.031_bib8","first-page":"938","article-title":"Marked hyperlipidemia on ritonavir therapy","volume":"11","author":"Sullivan","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.cbi.2016.06.031_bib9","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/eurheartj\/eht528","article-title":"HIV infection and cardiovascular disease","volume":"1","author":"Hemkens","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cbi.2016.06.031_bib10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/09540121.2010.543885","article-title":"Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study","volume":"23","author":"Lake","year":"2011","journal-title":"AIDS Care"},{"key":"10.1016\/j.cbi.2016.06.031_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2015.08.036","article-title":"HIV infection induces structural and functional changes in high density lipoproteins","volume":"243","author":"Siegel","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.06.031_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S0036-46652008000400007","article-title":"Alterations in lipid transfer to high-density lipoprotein (HDL) and activity of paraoxonase-1 in HIV+ patients","volume":"50","author":"Daminelli","year":"2008","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.cbi.2016.06.031_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(05)70281-6","article-title":"Abnormal fat accumulation in patients with HIV-1 infection","volume":"351","author":"Lipsky","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2016.06.031_bib14","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","article-title":"\u201cBuffalo hump\u201d in men with HIV-1 infection","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2016.06.031_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal- fat accumulation associated with use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2016.06.031_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh013","article-title":"Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients","volume":"53","author":"Calza","year":"2004","journal-title":"JAC"},{"key":"10.1016\/j.cbi.2016.06.031_bib17","first-page":"236","article-title":"Effects of switching to protease inhibitor monotherapy on nucleoside analogue-related adverse events","volume":"16","author":"Clumeck","year":"2014","journal-title":"AIDS Rev."},{"key":"10.1016\/j.cbi.2016.06.031_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/ajcn\/87.6.1809","article-title":"Study of fat redistribution metabolic change in H. I. V. infection. simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects","volume":"87","author":"Scherzer","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.cbi.2016.06.031_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2009.06.011","article-title":"Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects","volume":"208","author":"Guaraldi","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.06.031_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/JOE-10-0272","article-title":"Lipodystrophy: metabolic insights from a rare disorder","volume":"207","author":"Huang-Doran","year":"2010","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.cbi.2016.06.031_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1152\/ajpendo.00056.2003","article-title":"Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy","volume":"286","author":"Johnson","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2016.06.031_bib22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dkn251","article-title":"HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options","volume":"62","author":"Mallewa","year":"2008","journal-title":"J.\u00a0Antymicrob. Chemother."},{"key":"10.1016\/j.cbi.2016.06.031_bib23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbalip.2009.09.018","article-title":"Drug induced lipotoxycity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment","volume":"1801","author":"Villarroya","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2016.06.031_bib24","first-page":"15","article-title":"Pathogenesis and treatment of lipodystrophy: what clinicians need to know","volume":"14","author":"Sattler","year":"2008","journal-title":"Top. HIV Med."},{"key":"10.1016\/j.cbi.2016.06.031_bib25","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1161\/CIRCULATIONAHA.110.973750","article-title":"Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats","volume":"122","author":"Gary-Bobo","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2016.06.031_bib26","doi-asserted-by":"crossref","first-page":"E558","DOI":"10.1152\/ajpendo.00167.2007","article-title":"HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus","volume":"294","author":"Carper","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2016.06.031_bib27","series-title":"Pharmacology. Basic Pharmacology","first-page":"2567","author":"Kostkowski","year":"2006"},{"key":"10.1016\/j.cbi.2016.06.031_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2016.06.031_bib29","first-page":"28","article-title":"Chronic action of association of zidovudine, lamivudine and ritonavir on pregnant rats. A biologic assay","volume":"38","author":"Wagner","year":"2011","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.cbi.2016.06.031_bib30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1194\/jlr.M200432-JLR200","article-title":"Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response","volume":"44","author":"Cabana","year":"2003","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cbi.2016.06.031_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/JOE-09-0298","article-title":"Modulation of paraoxonase 1 and N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat","volume":"204","author":"Be\u0142towski","year":"2010","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.cbi.2016.06.031_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects","volume":"15","author":"Purnell","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.cbi.2016.06.031_bib33","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","article-title":"Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study","volume":"160","author":"Tsioridas","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cbi.2016.06.031_bib34","first-page":"3734","article-title":"Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome","volume":"82","author":"Grunfeld","year":"1997","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2016.06.031_bib35","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","article-title":"HIV protease inhibitors stimulate hepatic triglyceride stimulus","volume":"20","author":"Lenhard","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2016.06.031_bib36","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A\u00a0syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.cbi.2016.06.031_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A\u00a0syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance due to protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.cbi.2016.06.031_bib38","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2016.06.031_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-5-2","article-title":"Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment","volume":"5","author":"Keiser","year":"2005","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cbi.2016.06.031_bib40","unstructured":"Lipid metabolism and cardiovascular risk in HIV infection: new perspectives and the role of nevirapine."},{"issue":"7","key":"10.1016\/j.cbi.2016.06.031_bib41","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1086\/423385","article-title":"Long-term efficacy and safety of protease inhibitor switching to nevirapine in HIV-infected patients with undetectable virus load","volume":"39","author":"Gil","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cbi.2016.06.031_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2015.08.036","article-title":"HIV infection induces structural and functional changes in high density lipoproteins","volume":"243","author":"Siegel","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.06.031_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S0036-46652008000400007","article-title":"Alterations in lipid transfer to highdensity lipoprotein (HDL) and activity of paraoxonase-1 in HIV+ patients","volume":"50","author":"Daminelli","year":"2008","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.cbi.2016.06.031_bib44","first-page":"480201","article-title":"Human Paraoxonase-1 activity is related to the number of CD4+ T-cells and is restored by antiretroviral therapy in HIV-1-infected individuals","volume":"6","author":"Morganti Ferreira Maselli","year":"2014","journal-title":"Dis. Markers"},{"key":"10.1016\/j.cbi.2016.06.031_bib45","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.RES.0000185320.82962.F7","article-title":"Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation","volume":"97","author":"Moore","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2016.06.031_bib46","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/01.ATV.19.9.2214","article-title":"Human serum paraoxonase\/arylesterase\u2019s retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A-I stabilizes activity","volume":"19","author":"Sorenson","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2016.06.031_bib47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2016.06.031_bib48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbrc.2004.04.056","article-title":"Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells","volume":"318","author":"Mackness","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2016.06.031_bib49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.antiviral.2010.02.004","article-title":"Effect of ritonavir and atazanavir on human subcutaneous preadipocyte proliferation and differentiation","volume":"86","author":"Caso","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.cbi.2016.06.031_bib50","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance","volume":"50","author":"Caron","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2016.06.031_bib51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.atherosclerosis.2008.05.013","article-title":"Pitavastatin induces PON1 expression through p44\/42 mitogen-activated protein kinase signaling cascade in Huh7 cells","volume":"202","author":"Arii","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.06.031_bib52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2009.08.051","article-title":"Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway","volume":"208","author":"Khateeb","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2016.06.031_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.RES.87.1.45","article-title":"Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis","volume":"87","author":"Jakubowski","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2016.06.031_bib54","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1096\/fasebj.13.15.2277","article-title":"Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels","volume":"13","author":"Jakubowski","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.cbi.2016.06.031_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00018-003-3204-7","article-title":"Molecular basis of homocysteine toxicity in humans","volume":"61","author":"Jakubowski","year":"2004","journal-title":"Cell Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.cbi.2016.06.031_bib56","first-page":"155","article-title":"The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease","volume":"59","author":"Jakubowski","year":"2008","journal-title":"J.\u00a0Physiol. Pharmacol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716302733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716302733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:46:02Z","timestamp":1762112762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279716302733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":56,"alternative-id":["S0009279716302733"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2016.06.031","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2016.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}